PMID- 14709415 OWN - NLM STAT- MEDLINE DCOM- 20041104 LR - 20191108 IS - 0896-8411 (Print) IS - 0896-8411 (Linking) VI - 22 IP - 1 DP - 2004 Feb TI - Association between IL-18 gene promoter polymorphisms and CTLA-4 gene 49A/G polymorphism in Japanese patients with type 1 diabetes. PG - 73-8 AB - Interleukin-18 (IL-18) is a potent proinflammatory cytokine which is strongly associated with the development of diabetes in NOD mice. To test the putative involvement of IL-18 gene polymorphism in predisposition to human type 1 diabetes, the SNPs at position -607 (C/A) and -137 (G/C) in the promoter region of IL-18 gene were analyzed by sequence-specific PCR in 116 patients with type 1 diabetes and 114 normal controls. A linkage disequilibrium found only three of the four possible haplotypes defined by these SNPs. The distribution of the IL-18 gene genotypes at position -607 was significantly different between patients with type 1 diabetes and normal controls (P=0.023). Furthermore, there was a significant increase in haplotype 1 (-607C/-137G) in the patients compared with controls (P=0.006). The association study of the susceptible CTLA-4 genotype (GG at nucleotide position 49 in exon 1) or HLA-DR4-DQB1*0401 and type 1 diabetes showed that the predisposing IL-18 gene haplotype modulates the risk on CTLA-4 GG genotype, but not on HLA-DR4-DQB1*0401 haplotype. Among subjects carrying the CTLA-4 GG genotype, the frequency of IL-18 haplotype 1 in patients with type 1 diabetes was significantly higher than that in controls (91% vs. 71%, P=0.012). However, IL-18 haplotype 1 was not frequent in patients who do not exhibit the CTLA-4 high-risk genotype. These results suggest that the IL-18 gene polymorphism is associated with a type 1 diabetes susceptibility, and there might be a gene-gene interaction between IL-18 gene with susceptible CTLA-4 gene. FAU - Ide, Akane AU - Ide A AD - The First Department of Internal Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan. FAU - Kawasaki, Eiji AU - Kawasaki E FAU - Abiru, Norio AU - Abiru N FAU - Sun, Fuyan AU - Sun F FAU - Kobayashi, Masakazu AU - Kobayashi M FAU - Fukushima, Tetsuya AU - Fukushima T FAU - Takahashi, Ryoko AU - Takahashi R FAU - Kuwahara, Hironaga AU - Kuwahara H FAU - Kita, Atsushi AU - Kita A FAU - Oshima, Katsuya AU - Oshima K FAU - Uotani, Shigeo AU - Uotani S FAU - Yamasaki, Hironori AU - Yamasaki H FAU - Yamaguchi, Yoshihiko AU - Yamaguchi Y FAU - Eguchi, Katsumi AU - Eguchi K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - J Autoimmun JT - Journal of autoimmunity JID - 8812164 RN - 0 (Antigens, CD) RN - 0 (Antigens, Differentiation) RN - 0 (CTLA-4 Antigen) RN - 0 (CTLA4 protein, human) RN - 0 (Ctla4 protein, mouse) RN - 0 (Interleukin-18) SB - IM MH - Adult MH - Aged MH - Animals MH - Antigens, CD MH - Antigens, Differentiation/*genetics MH - CTLA-4 Antigen MH - Case-Control Studies MH - Diabetes Mellitus, Type 1/*genetics MH - Female MH - Genes, MHC Class II MH - Humans MH - Interleukin-18/*genetics MH - Japan MH - Male MH - Mice MH - Middle Aged MH - *Polymorphism, Genetic MH - Promoter Regions, Genetic EDAT- 2004/01/08 05:00 MHDA- 2004/11/05 09:00 CRDT- 2004/01/08 05:00 PHST- 2004/01/08 05:00 [pubmed] PHST- 2004/11/05 09:00 [medline] PHST- 2004/01/08 05:00 [entrez] AID - S0896841103001707 [pii] AID - 10.1016/j.jaut.2003.10.001 [doi] PST - ppublish SO - J Autoimmun. 2004 Feb;22(1):73-8. doi: 10.1016/j.jaut.2003.10.001.